iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Q2FY24 Review: KIMS: In-line quarter, barring minor delays in projects

9 Nov 2023 , 11:15 AM

KIMS’ Q2 performance was in-line with analysts of IIFL Securities expectations, with IP volume/ARPOB growth of 10/6% YoY, driving 16/15% YoY revenue/Ebitda growth during the quarter. Aided by seasonal benefit, occupancies improved across all clusters including Sunshine and Nagpur, with overall occupancies expanding YoY/QoQ from 73/70% to 76% in Q2 (on census beds). While few of KIMS’ expansion projects seem delayed by 6-9 months, analysts of IIFL Securities note that KIMS will still be adding 1,000 beds (25% incremental capacity) across Nashik, Thane and Bangalore by the end of Q4FY25 and 700 beds (15% incremental capacity) in Kondapur and Anantapur by early FY27, which would help to drive medium-term growth. Near-term growth drivers include further improvement in occupancies of Telangana, Sunshine and Nagpur hospitals. Analysts of IIFL Securities maintain their estimate of 18% Ebitda Cagr over FY23-26. Reiterate BUY, with their TP of Rs2140 being pegged at 22.5x 2YF Ebitda. 

Ramp-up at Sunshine and Nagpur progressing well: 

Occupancies in Sunshine/Nagpur hospitals improved QoQ from 44/63% to 53/80% resp. in Q2, partly aided by the seasonal business. Mgmt indicated that growth has sustained for both Sunshine and Nagpur in Oct/Nov’23. With Sunshine’s new Begumpet facility commencing operations from Nov’23 and 50% new doctor hirings completed in Nagpur, occupancies and margins in both these hospitals will continue to improve. Analysts of IIFL Securities expect Sunshine’s margins to expand from 23% in H1FY24 to 28% in FY25 led by rental cost savings of 450bps, while Nagpur’s margins will likely improve from 12% to 17% in FY25. 

40% incremental capacity will be added by early FY27: 

KIMS intends to add 1,000 beds across Nashik (300), Thane (300) & Bangalore (400) by the end of 4QFY25 and 700 beds in Kondapur & Anantapur by early FY27. Thane will be either an O&M hospital (KIMS Rs1.2bn investment + investor Rs3bn) or entirely owned by KIMS (Rs4.3bn investment). Bangalore will likely see commissioning of 2 hospitals (700 beds in total), with the deal for the 2nd hospital (300 beds) expected to be signed by Jan/Feb’24. Analysts of IIFL Securities assume Rs150m Ebitda drag from these new hospitals in FY25ii. 

Analysts of IIFL Securities expect KIMS overall revenue/Ebitda to clock 17/18% Cagr over FY23-26, driven by 10/14% revenue Cagr in Telangana/AP hospitals, ramp-up in Sunshine/Nagpur hospitals, and aided by capacity additions from FY25. Margin improvement in Sunshine/Nagpur will help the company to absorb the Ebitda drag from the new hospitals in FY25.

Related Tags

  • KIMS
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Benchmark Indices Close on a Positive Note
14 Jun 2024|03:39 PM
Sensex and Nifty Surge
14 Jun 2024|01:47 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.